Feb 27, 2026 08:30AM
Jan 14, 2026 09:00AM
Jan 9, 2026 08:30AM
Jan 9, 2026 08:30AM
Dec 22, 2025 07:06AM
Dec 5, 2025 08:30AM
Nov 26, 2025 07:01AM CG Oncology adds Christina Rossi to board, Simone Song resigns
Nov 26, 2025 07:00AM
Nov 25, 2025 04:05PM
Nov 14, 2025 08:00AM
Oct 24, 2025 08:29AM
Oct 8, 2025 05:35AM
Sep 10, 2025 09:16AM
Sep 5, 2025 07:02AM CG Oncology reports 41.8% complete response rate at 24 months
Sep 5, 2025 07:00AM
Sep 3, 2025 08:01AM
Sep 3, 2025 08:00AM
Aug 8, 2025 08:00AM
Jul 29, 2025 04:09PM
Jul 29, 2025 04:05PM
May 13, 2025 08:00AM CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
Apr 28, 2025 07:22AM
Apr 26, 2025 04:10PM
Apr 24, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 28, 2025 07:00AM
Mar 24, 2025 08:04AM
Mar 24, 2025 08:00AM Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Mar 12, 2025 08:00AM
Dec 5, 2024 07:00AM
Dec 2, 2024 08:00AM
Nov 20, 2024 08:00AM
Nov 12, 2024 08:00AM
Nov 11, 2024 08:00AM
Oct 21, 2024 06:06AM Goldman Sachs Reiterates Buy Rating on CG Oncology (CGON)
Sep 26, 2024 10:45AM
Aug 8, 2024 08:23AM
Jun 18, 2024 08:00AM
Jun 6, 2024 12:15PM
Jun 6, 2024 12:14PM
May 24, 2024 08:00AM
May 3, 2024 11:23AM Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Jan 2, 2024 05:19PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All